Step by Stepa HemeOncBuddy patient portal

Tisotumab vedotin

Illustration: Tisotumab vedotin

Say it: ty-SOH-too-mab veh-DOH-tin · Brand names: Tivdak

Tisotumab vedotin is a targeted medicine that delivers a strong cancer drug straight to cancer cells that have a protein called tissue factor.

What it is

It is made of two parts joined together: an antibody that finds a protein called tissue factor on cancer cells, and a strong cancer medicine. The antibody carries the medicine straight to the cancer cell, so more of it reaches the cancer and less reaches healthy cells. Once inside, the medicine stops the cancer cell from dividing.

Often used for

How you get it

You get it as an infusion into a vein at a clinic, and each infusion takes about 30 minutes. Most people get it once every 3 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Tisotumab vedotin?
Tisotumab vedotin is a targeted medicine that delivers a strong cancer drug straight to cancer cells that have a protein called tissue factor. Brand names: Tivdak.
What is Tisotumab vedotin used for?
cervical cancer that has come back or spread after chemotherapy.
How is Tisotumab vedotin given?
You get it as an infusion into a vein at a clinic, and each infusion takes about 30 minutes. Most people get it once every 3 weeks. Your schedule may be different.
What are the common side effects of Tisotumab vedotin?
Dry, red, or irritated eyes. Feeling tired. Nausea. Numbness or tingling in your hands or feet. Hair loss. Nosebleeds or other bleeding. Low blood counts. Rash.
When should I call my care team while taking Tisotumab vedotin?
Any new or worse vision problems, eye pain, or red eyes; Bleeding that will not stop, coughing or vomiting blood, or blood in your urine or stool; New or worse cough or trouble breathing; A rash with blisters, peeling skin, or mouth sores; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.